Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 2196986, 7 pages
http://dx.doi.org/10.1155/2016/2196986
Research Article

Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus

Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China

Received 1 April 2016; Accepted 13 July 2016

Academic Editor: Tinatin Chikovani

Copyright © 2016 Qingjun Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rahman and D. A. Isenberg, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, no. 9, pp. 929–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Pickering and M. J. Walport, “Links between complement abnormalities and systemic lupus erythematosus,” Rheumatology, vol. 39, no. 2, pp. 133–141, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Walport and K. A. Davies, “Complement and immune complexes,” Research in Immunology, vol. 147, no. 2, pp. 103–109, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Shakib, The Human IgG Subclasses: Molecular Analysis of Structure, Function and Regulation, Elsevier, New York, NY, USA, 2013.
  5. R. R. Rich, T. A. Fleisher, W. T. Shearer et al., Clinical Immunology: Principles and Practice, Elsevier Health Sciences, 2012.
  6. A. M. Davies, T. Rispens, P. Ooijevaar-De Heer et al., “Structural determinants of unique properties of human IgG4-Fc,” Journal of Molecular Biology, vol. 426, no. 3, pp. 630–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Nirula, S. M. Glaser, S. L. Kalled, and F. R. Taylora, “What is IgG4? A review of the biology of a unique immunoglobulin subtype,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 119–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. C. Aalberse, S. O. Stapel, J. Schuurman, and T. Rispens, “Immunoglobulin G4: an odd antibody,” Clinical and Experimental Allergy, vol. 39, no. 4, pp. 469–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Liu and K. May, “Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function,” mAbs, vol. 4, no. 1, pp. 17–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Vlug, E. J. Nieuwenhuys, R. V. W. van Eijk, H. G. M. Geertzen, and A. J. Van Houte, “Nephelometric measurements of human IgG subclasses and their reference ranges,” Annales de Biologie Clinique, vol. 52, no. 7-8, pp. 561–567, 1994. View at Google Scholar · View at Scopus
  11. M. Pressac, F. Allouche, R. Circaud, and P. Aymard, “Evaluation of human IgG subclass assays on Beckman array,” Annals of Clinical Biochemistry, vol. 32, no. 3, pp. 281–288, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. B. V. Ayyar, S. Arora, C. Murphy, and R. O'Kennedy, “Affinity chromatography as a tool for antibody purification,” Methods, vol. 56, no. 2, pp. 116–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Doi, M. Mayumi, K. Kanatsu, F. Suehiro, and Y. Hamashima, “Distribution of IgG subclasses in membranous nephropathy,” Clinical and Experimental Immunology, vol. 58, no. 1, pp. 57–62, 1984. View at Google Scholar · View at Scopus
  14. H. Imai, K. Hamai, A. Komatsuda, H. Ohtani, and A. B. Miura, “IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis,” Kidney International, vol. 51, no. 1, pp. 270–276, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. S. Song, K.-W. Min, J. H. Kim, G.-H. Kim, and M. H. Park, “Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 12, pp. 1947–1955, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Isenberg, J. J. Manson, M. R. Ehrenstein, and A. Rahman, “Fifty years of anti-ds DNA antibodies: are we approaching journey's end?” Rheumatology, vol. 46, no. 7, pp. 1052–1056, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Sui, Q. Lin, Z. Xu et al., “Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis,” Journal of Clinical Immunology, vol. 33, no. 2, pp. 378–387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., “Development of autoantibodies before the clinical onset of systemic lupus erythematosus,” The New England Journal of Medicine, vol. 349, no. 16, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Morland, J. Michael, and D. Adu, “IgG subclasses of PEG precipitable IgG in systemic lupus erythematosus sera,” Clinical Nephrology, vol. 31, no. 4, pp. 204–209, 1989. View at Google Scholar · View at Scopus
  20. G.-G. Lin and J.-M. Li, “IgG subclass serum levels in systemic lupus erythematosus patients,” Clinical Rheumatology, vol. 28, no. 11, pp. 1315–1318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Sun, R.-F. Gao, Y. Chen, Y.-Y. Su, and L.-L. Dong, “Measurement of serum IgG4 levels by an established ELISA system and its clinical applications in autoimmune diseases,” Journal of Huazhong University of Science and Technology [Medical Sciences], vol. 33, no. 4, pp. 611–614, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Kuroki, T. Shibata, H. Honda, D. Totsuka, K. Kobayashi, and T. Sugisaki, “Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, and idiopathic membranous nephropathy,” Internal Medicine, vol. 41, no. 11, pp. 936–942, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Zhang, P. Li, D. Wu et al., “Serum IgG subclasses in autoimmune diseases,” Medicine, vol. 94, no. 2, p. e387, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. X. Yu, Preliminary Study on the Relationship between IgG and Systemic Lupus Erythematosus, North Sichuan Medical College, Nanchong, China, 2013 (Chinese).
  25. J. H. Stone, Y. Zen, and V. Deshpande, “IgG4-related disease,” The New England Journal of Medicine, vol. 366, no. 6, pp. 539–551, 2012. View at Google Scholar
  26. T. Kamisawa, Y. Zen, S. Pillai, and J. H. Stone, “IgG4-related disease,” The Lancet, vol. 385, no. 9976, pp. 1460–1471, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Duquerroy, E. A. Stura, S. Bressanelli et al., “Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation,” Journal of Molecular Biology, vol. 368, no. 5, pp. 1321–1331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. P. Cui, J. L. Xie, L. K. Yu et al., “Anti-CCP/RA33/AKA/RF autoantibodies in rheumatoid arthritis: a clinical diagnosis,” Shanghai Journal of Medical Laboratory Sciences, vol. 18, no. 4, pp. 221–222, 2003 (Chinese). View at Google Scholar
  29. E. Muso, M. Yashiro, Y. Ito, H. Yoshida, and S. Sasayama, “Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients,” Nihon Jinzo Gakkai Shi, vol. 36, no. 4, pp. 345–354, 1994. View at Google Scholar · View at Scopus
  30. U. E. Höpken, B. Lu, N. P. Gerard, and C. Gerard, “Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor,” Journal of Experimental Medicine, vol. 186, no. 5, pp. 749–756, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Heller, J. E. Gessner, R. E. Schmidt, A. Klos, W. Bautsch, and J. Köhl, “Cutting edge: Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis,” Journal of Immunology, vol. 162, no. 10, pp. 5657–5661, 1999. View at Google Scholar · View at Scopus
  32. S. M. Canfield and S. L. Morrison, “The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region,” The Journal of Experimental Medicine, vol. 173, no. 6, pp. 1483–1491, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. M.-H. Tao, S. M. Canfield, and S. L. Morrison, “The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain,” Journal of Experimental Medicine, vol. 173, no. 4, pp. 1025–1028, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. M.-H. Tao, R. I. F. Smith, and S. L. Morrison, “Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation,” Journal of Experimental Medicine, vol. 178, no. 2, pp. 661–667, 1993. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Della-Torre, M. Lanzillotta, and C. Doglioni, “Immunology of IgG4-related disease,” Clinical and Experimental Immunology, vol. 181, no. 2, pp. 191–206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. J. S. van der Zee, P. van Swieten, and R. C. Aalberse, “Inhibition of complement activation by IgG4 antibodies,” Clinical and Experimental Immunology, vol. 64, no. 2, pp. 415–422, 1986. View at Google Scholar · View at Scopus
  37. M. van der Neut Kolfschoten, J. Schuurman, M. Losen et al., “Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange,” Science, vol. 317, no. 5844, pp. 1554–1557, 2007. View at Publisher · View at Google Scholar · View at Scopus